These metabolites upregulate hepatic CXCR6+ natural killer T (NKT) cells, thereby suppressing and eliminating HCC cells while enhancing the therapeutic efficacy of ICIs (67). This evidence concerns the gene CXCR6 and hepatocellular carcinoma.